The Chinese Journal of Natural Medicines, published by the esteemed CHINESE JOURNAL NATURAL MEDICINES, plays a pivotal role in the exploration and advancement of complementary and alternative medicine. With an ISSN of 2095-6975 and an E-ISSN of 1875-5364, this journal is recognized for its commitment to high-quality research and innovative findings in the realms of drug discovery and miscellaneous medical fields. Operating from China, it has earned a prestigious reputation in the academic community, achieving Q1 status in Complementary and Alternative Medicine and Q2 rankings in both Drug Discovery and Miscellaneous Medicine as of 2023, solidifying its influence within the scientific discourse. Researchers and professionals will find valuable insights here as the journal explores the intersection of traditional natural medicines with modern pharmacological science, making it an essential resource for anyone dedicated to the field. With a convergence period from 2004 to 2024, the journal continues to champion open dialogue and disseminate significant findings critical for the development of effective natural therapies.

Journal of Pharmacy & Pharmacognosy Research, published by JOURNAL PHARMACY & PHARMACOGNOSY RESEARCH-JPPRES, is a prominent open-access journal established in 2013, headquartered in Antofagasta, Chile. With a focus on the fields of Complementary and Alternative Medicine, Drug Discovery, Pharmaceutical Science, Pharmacology, and Pharmacy, this journal is recognized for its commitment to advancing research and disseminating knowledge within these important areas. With a current impact factor that reflects its academic rigor and relevance, the journal has achieved substantial recognition, evident by its Q2 and Q3 quartile rankings in multiple categories, indicating its growing influence on the scientific community. The Scopus rankings further highlight its standing in pharmacy and pharmacological disciplines, providing a valuable platform for researchers, professionals, and students to share their findings and insights. With its open access model, the journal ensures that high-quality research is available to a global audience, paving the way for collaborative advancements in pharmaceutical sciences.

The Indian Journal of Traditional Knowledge, published by the NATL INST SCIENCE COMMUNICATION-NISCAIR, serves as a pivotal platform for scholarship in the fields of traditional knowledge, complementary and alternative medicine, and manual therapy. With an ISSN of 0972-5938 and an E-ISSN of 0975-1068, this esteemed journal has embraced open access since 2002, ensuring that research is widely available to practitioners and scholars alike. Based in New Delhi, India, and with a commendable Q2 ranking in both the Complementary and Alternative Medicine and Complementary and Manual Therapy categories as of 2023, this journal aims to bridge the gap between traditional practices and modern scientific inquiry. By publishing innovative research and review articles, it not only highlights the rich cultural heritage and knowledge systems of India but also contributes to the global discourse surrounding holistic health and wellness. Researchers, professionals, and students will find invaluable insights and significant advancements within its pages, making the Indian Journal of Traditional Knowledge an essential resource for anyone interested in the dynamic interplay between tradition and contemporary medical practice.

MEDICINE, published by Lippincott Williams & Wilkins, is an esteemed open access journal in the field of general medicine, holding a significant position with a Scopus rank of #190 out of 636 in its category (2023), placing it in the 70th percentile. Since its inception in 1922, MEDICINE has been a vital platform for researchers, professionals, and students to disseminate groundbreaking findings and advancements in the medical field. With the transition to open access in 2014, the journal ensures that valuable research is readily available to a global audience, fostering collaboration and innovation across diverse medical disciplines. Its current impact factor and influence in the miscellaneous medicine category (Q3) reflect its commitment to supporting rigorous peer-review processes and promoting scholarly excellence. Located in Philadelphia, PA, the journal covers a wide range of topics, making it a crucial resource for those dedicated to the betterment of healthcare and medical education.

JOURNAL OF HERBS SPICES AND MEDICINAL PLANTS, published by Taylor & Francis Ltd, serves as a pivotal platform for researchers and professionals in the fields of Complementary and Alternative Medicine and Pharmacology. With an ISSN of 1049-6475 and E-ISSN of 1540-3580, this journal is dedicated to advancing the understanding of the therapeutic potential of herbs, spices, and various medicinal plants, and showcases high-quality, peer-reviewed research from 1992 to 2024. As of 2023, it holds a respectable Q3 ranking in both relevant categories, exhibiting its growing influence within the academic community. The journal is not open access, yet it remains a vital resource for those exploring the diverse applications and efficacy of plant-based therapies. Researchers and students alike will benefit from the journal’s commitment to disseminating innovative findings that can enhance the quality of life through natural remedies, thereby contributing significantly to the global discourse on herbal medicine.

Journal of Traditional Chinese Medicine, with the ISSN 0255-2922 and E-ISSN 1577-7014, is a distinguished publication dedicated to exploring the rich heritage and contemporary applications of Chinese medicinal practices. Published by JOURNAL TRADITIONAL CHINESE MED in China, this journal contributes significantly to the field of Complementary and Alternative Medicine, holding a respectable Q2 ranking in this category according to the 2023 metrics, and a Q3 ranking in miscellaneous medicine. With its coverage spanning from 1996 to 2024, the journal aims to advance scholarly research and foster an understanding of traditional Chinese healing methodologies, blending ancient wisdom with modern healthcare paradigms. While currently not classified as Open Access, it provides critical insights and detailed analyses that are invaluable for researchers, healthcare professionals, and students interested in the intersection of tradition and innovation in medical practices.

Journal of Natural Medicines, published by SPRINGER JAPAN KK, is a leading academic journal that plays a pivotal role in the advancement of research in the fields of Complementary and Alternative Medicine, Drug Discovery, Molecular Medicine, Organic Chemistry, and Pharmaceutical Science. Established in 1994 and set to continue until 2024, this journal serves as a vital conduit for the dissemination of groundbreaking research and innovative ideas that bridge traditional medicinal knowledge and modern scientific inquiry. With its impressive ranking in Scopus—ranking #12 out of 105 in Complementary and Alternative Medicine and holding a Q1 category quartile for 2023—it stands as a reputable source for high-quality, peer-reviewed articles. The journal's commitment to excellence is further underscored by its inclusion in the Springer network, providing researchers, professionals, and students with valuable insights and the latest developments in natural medicines. Although this journal operates under a subscription model, its profound impact on these interdisciplinary fields makes it an essential resource for anyone engaged in the study or practice of natural medicinal therapies.

INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS, published by Begell House Inc, stands as a pivotal resource in the realm of mycology and its applications in health and medicine. With an ISSN of 1521-9437 and an E-ISSN of 1940-4344, this journal has carved a niche for itself since its inception in 2005, converging knowledge and research through 2024 and beyond. Renowned for its dedication to advancing the understanding of medicinal mushrooms, this journal is categorized in the third quartile across multiple categories, including Applied Microbiology and Biotechnology, Drug Discovery, and Pharmacology, indicating its relevance in these critical scientific fields. Though it operates under a traditional subscription model, the journal's emphasis on quality research makes it an essential read for researchers, professionals, and students seeking comprehensive insights into the therapeutic potential of fungi. As the landscape of pharmacology and biotechnology expands, the INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS remains a cornerstone for innovative exploration and discovery in the application of mushrooms within medicine.

BMC Complementary Medicine and Therapies is a leading open-access journal published by BMC in the United Kingdom, dedicated to advancing the field of complementary and alternative medicine. Since its inception in 2020, this journal has rapidly gained recognition, achieving a prestigious Q1 ranking in the category of Complementary and Alternative Medicine as of 2023, and ranking #18 out of 105 in the Scopus database, placing it in the 83rd percentile among its peers. The journal’s mission is to disseminate high-quality research that contributes to a better understanding of the efficacy, safety, and practical application of complementary therapies. With its open-access model, BMC Complementary Medicine and Therapies ensures that valuable research findings are freely accessible to researchers, healthcare practitioners, and students alike, fostering collaboration and innovation across disciplines. The journal publishes original research, reviews, and clinical studies, providing a comprehensive platform for the exploration of diverse therapeutic modalities.

Pakistan Journal of Pharmaceutical Sciences, published by the University of Karachi, serves as a vital platform for advancing research in the field of pharmaceutical sciences. With a strong commitment to disseminating innovative findings and critical studies since its inception in 1995, the journal focuses on a wide array of topics including pharmacology, toxicology, and pharmaceutics. With an ISSN of 1011-601X, it holds a reputable position within the academic community, reflecting its Q3 category ranking in Pharmaceutical Science as of 2023. While the journal is currently not designated as Open Access, it remains accessible through institutional subscriptions, ensuring that both emerging and established researchers can contribute to and benefit from its scholarly content. This publication not only promotes scientific dialogue but also aims to bridge the gap between academia and industry, appealing to a diverse audience of researchers, professionals, and students seeking to stay informed about the latest advancements and trends in pharmaceutical research.